Nav: Home

UMMS scientist designs lamp light operative photodynamic molecules for tumor therapy

December 05, 2016

WORCESTER: UMass Medical School scientist Gang Han, PhD, and his team have designed a new class of molecules used in photodynamic therapy that are able to direct lamp light deep into tissue to kill cancer tumors.

In a new paper published in the Journal of the American Chemical Society, Dr. Han, associate professor of biochemistry & molecular pharmacology, outlines how the carbazole-substituted BODIPY (Car-BDP) molecules, which possess an intense, broad NIR absorption band with a remarkably high singlet oxygen quantum yield, will further the potential clinical application for photodynamic therapy.

"This study signals a major step forward in photodynamic therapy by developing a new class of NIR-absorbing biodegradable organic nanoparticles for a highly effective targeting and treatment of deep-tissue tumors," Han said.

Tissue penetration depth is a major challenge in practical photodynamic therapy. Traditionally, it involves the patient receiving a nontoxic light-sensitive drug, which is absorbed by all the body's cells, including cancerous ones. A red laser light specifically tuned to the drug molecules is then selectively turned on in the tumor area. When the red light interacts with the photosensitive drug, it produces a highly reactive form of oxygen (singlet oxygen) that kills the malignant cancer cells while leaving most neighboring cells unharmed.

Based on research by the Han Lab at UMMS and colleagues, the process might become simpler, more effective and cost efficient.

Han explained that after being encapsulated with biodegradable polymers, Car-BDP molecules can form uniform and small, organic nanoparticles that are water-soluble and tumor targetable. Used in conjunction with a record low-power-density and cost-effective incoherent lamp light, rather than the coherent high power laser light that is used in the existing therapy, the molecules can be tracked as they spread through the body, deep into the tissue and to outline and kill cancerous tumors. More interestingly, the organic nanoparticles were found to have an extremely long circulating time and can be removed from body, which is essential for new practical photodynamic therapy drug development, Han said.

Han said the combination is "sufficient to monitor and trigger practical photodynamic therapy effect of these nanoparticles within a wide variety of deep-tissue level tumors such as lung, colon, prostate and breast cancers."

In addition, the potential new platform for precise tumor-targeting theranostics and novel opportunities with low power lamp light could allow for future affordable clinical cancer treatment that patients may be able to manage in their homes or resource deficient areas, such as on battlefields and in developing countries.
-end-
About UMass Medical School:

The University of Massachusetts Medical School (UMMS), one of five campuses of the University system, comprises the School of Medicine, the Graduate School of Biomedical Sciences, the Graduate School of Nursing, a thriving research enterprise and an innovative public service initiative, Commonwealth Medicine. Its mission is to advance the health of the people of the commonwealth through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education. The Medical School attracts more than $240 million annually in research funding, placing it among the top 50 medical schools in the nation. In 2006, UMMS's Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator and the Blais University Chair in Molecular Medicine, was awarded the Nobel Prize in Physiology or Medicine, along with colleague Andrew Z. Fire, PhD, of Stanford University, for their discoveries related to RNA interference (RNAi). The 2013 opening of the Albert Sherman Center ushered in a new era of biomedical research and education on campus. Designed to maximize collaboration across fields, the Sherman Center is home to scientists pursuing novel research in emerging scientific fields with the goal of translating new discoveries into innovative therapies for human diseases.

University of Massachusetts Medical School

Related Nanoparticles Articles:

How to get more cancer-fighting nanoparticles to where they are needed
University of Toronto Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour.
Nanoparticles: Acidic alert
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have synthesized nanoparticles that can be induced by a change in pH to release a deadly dose of ionized iron within cells.
3D reconstructions of individual nanoparticles
Want to find out how to design and build materials atom by atom?
Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.
Sweet nanoparticles trick kidney
Researchers engineer tiny particles with sugar molecules to prevent side effect in cancer therapy.
A megalibrary of nanoparticles
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles.
Dialing up the heat on nanoparticles
Rapid progress in the field of metallic nanotechnology is sparking a science revolution that is likely to impact all areas of society, according to professor of physics Ventsislav Valev and his team at the University of Bath in the UK.
Illuminating the world of nanoparticles
Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have developed a light-based device that can act as a biosensor, detecting biological substances in materials; for example, harmful pathogens in food samples.
What happens to gold nanoparticles in cells?
Gold nanoparticles, which are supposed to be stable in biological environments, can be degraded inside cells.
Lighting up cardiovascular problems using nanoparticles
A new nanoparticle innovation that detects unstable calcifications that can trigger heart attacks and strokes may allow doctors to pinpoint when plaque on the walls of blood vessels becomes dangerous.
More Nanoparticles News and Nanoparticles Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.